The Ensign Group, Inc.
General ticker "ENSG" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $8.5B (TTM average)
The Ensign Group, Inc. follows the US Stock Market performance with the rate: 61.8%.
Estimated limits based on current volatility of 1.6%: low 178.71$, high 184.63$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-09-30, amount 0.06$ (Y0.13%)
- Total employees count: 39300 (+11.3%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Healthcare policy changes, Political conditions, Government audits, Acquisition/divestiture risks, Insurance risks
- Current price 11.0% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [118.51$, 160.31$]
- 2025-12-31 to 2026-12-31 estimated range: [123.15$, 167.81$]
Financial Metrics affecting the ENSG estimates:
- Negative: with PPE of 24.4 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 8.41
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 6.01
- Positive: Interest expense per share per price, % of 0.11 <= 0.79
- Positive: 18.93 < Shareholder equity ratio, % of 39.34 <= 41.86
- Negative: Investing cash flow per share per price, % of -5.12 <= -4.48
- Positive: 0 < Industry operating cash flow per share per price (median), % of 3.25
- Positive: Inventory ratio change, % of -0.15 <= 0
- Negative: Operating cash flow per share per price, % of 4.56 <= 6.82
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term ENSG quotes
Long-term ENSG plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3,025.47MM | $3,729.36MM | $4,260.48MM |
| Operating Expenses | $2,728.64MM | $3,473.99MM | $3,902.18MM |
| Operating Income | $296.82MM | $255.37MM | $358.30MM |
| Non-Operating Income | $-7.74MM | $17.39MM | $27.79MM |
| Interest Expense | $8.93MM | $8.09MM | $8.29MM |
| Income(Loss) | $289.09MM | $272.76MM | $386.09MM |
| Taxes | $64.44MM | $62.91MM | $87.64MM |
| Profit(Loss)* | $224.68MM | $209.40MM | $297.97MM |
| Stockholders Equity | $1,247.33MM | $1,491.87MM | $1,837.11MM |
| Assets | $3,452.02MM | $4,177.54MM | $4,669.36MM |
| Operating Cash Flow | $272.51MM | $376.67MM | $347.19MM |
| Capital expenditure | $87.55MM | $106.18MM | $158.24MM |
| Investing Cash Flow | $-186.18MM | $-182.70MM | $-390.05MM |
| Financing Cash Flow | $-32.26MM | $-0.61MM | $-2.16MM |
| Earnings Per Share** | $4.09 | $3.76 | $5.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.